Pharmaceuticals
Drug development, generics, APIs, and regulatory approvals.
Key Insights
Key Principles
Biosimilar Pipeline Depth
Indian biotech firms are valued primarily on the breadth and advancement stage of their biosimilar pipelines targeting p...Analytical Characterization Capability
CDSCO's 2025 biosimilar guidelines permit Phase 3 clinical trial waivers when analytical and functional comparability is...Biologics Manufacturing Scale
Biosimilar manufacturing requires fermentation, purification, and cold-chain infrastructure with minimum viable capex of...Current Trends
CDSCO Guidelines Global Harmonization
India's 2025 draft biosimilar guidelines align with EMA and MHRA standards, permitting conditional Phase 3 waivers and r...Biopharma SHAKTI Initiative Funding
The government's Biopharma SHAKTI scheme with Rs 10,000 crore allocation aims to boost domestic biopharmaceutical innova...Global Biologics Patent Cliff
Patent expirations of blockbuster biologics including adalimumab, pembrolizumab, and ustekinumab create a multi-billion-...Catalysts & Inflection Points
US Biosimilar Interchangeability Designations
Indian-manufactured biosimilars receiving US FDA interchangeability designations would enable automatic pharmacy substit...PLI for Biopharmaceuticals Expansion
Extension of PLI incentives specifically for biologics manufacturing beyond the current bulk drug focus would reduce pay...WHO Prequalification of Biosimilars
WHO prequalification would open procurement channels across 100+ low- and middle-income countries through UNICEF, Global...Key Metrics
Biosimilar Pipeline Risk-Adjusted NPV
Risk-adjusted net present value of the biosimilar pipeline accounting for clinical stage, regulatory pathway, and target...Regulatory Filing Success Rate
Percentage of biosimilar submissions to CDSCO, EMA, and US FDA achieving first-cycle approval without complete response ...Biologics COGS per Gram
Manufacturing cost of goods per gram of biologic substance is the fundamental cost competitiveness metric, with Indian m...Top Companies
Sun Pharma.Inds.
Pharmaceuticals · BSE:524715Pharmaceuticals
BSE:524715
Divi's Lab.
Pharmaceuticals · BSE:532488Pharmaceuticals
BSE:532488
Torrent Pharma.
Pharmaceuticals · BSE:500420Pharmaceuticals
BSE:500420
Cipla
Pharmaceuticals · BSE:500087Pharmaceuticals
BSE:500087
Dr Reddy's Labs
Pharmaceuticals · BSE:500124Pharmaceuticals
BSE:500124
Lupin
Pharmaceuticals · BSE:500257Pharmaceuticals
BSE:500257
Zydus Lifesci.
Pharmaceuticals · BSE:532321Pharmaceuticals
BSE:532321
Mankind Pharma
Pharmaceuticals · BSE:543904Pharmaceuticals
BSE:543904
Alkem Lab
Pharmaceuticals · BSE:539523Pharmaceuticals
BSE:539523
Aurobindo Pharma
Pharmaceuticals · BSE:524804Pharmaceuticals
BSE:524804
Run AI analysis on Pharmaceuticals companies
Management credibility, business model strength, growth catalysts, and risk assessment with exact page citations.
Get started free